All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 16, 2022
Home » Authors » Bernard Banga

Bernard Banga

Articles

ARTICLES

Surgeons using Fluobeam LX in the operating room

Getinge to acquire near infrared imaging company Fluoptics for $27M

May 13, 2022
By Bernard Banga
No Comments
Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection Control SAS, acquire all outstanding shares in Fluoptics and will pay around $27 million in cash on closing the deal. Moreover, an additional earn-out of $6.25 million may be paid if agreed milestones are achieved.
Read More
05-09-ecential-robotics.png

Ecential and Amplitude Surgical enter partnership to develop robotic knee surgery solution

May 9, 2022
By Bernard Banga
No Comments
Ecential Robotics SAS and Amplitude Surgical SA reported a long-term partnership to develop a  robotic solution for knee surgery. These two French-based med-tech firms are combining their technology used for intraoperative 2D/3D imaging and surgical navigation in orthopedics.
Read More
José Maria Benlloch Baviera

EU funding new type of PET scanner used to monitor proton therapy in cancer

April 29, 2022
By Bernard Banga
No Comments
The Spanish National Research Council, CSIC, has just been awarded funding from the European Research Council to establish proof of concept for new type of flat-plate positron emission tomography scanner (PET) that can be attached to the patient’s body to accurately monitor cancer proton therapy results in real time.
Read More
Nanobiotix

Nanobiotix presents new preclinical data for its nano-radioenhancer combined with checkpoint inhibitors

April 25, 2022
By Bernard Banga
No Comments
Nanobiotix SA has just presented new data from an open-label preclinical study evaluating the action of its nanoparticle-enhanced radiotherapy, NBTXR3, with the triple blockade of PD-1, LAG-3, and TIGIT on mice carrying cancerous cells. PD-1, LAG-3 and TIGIT are three checkpoint inhibitors which regulate the natural killer cells usually targeted in combination therapy in immuno-oncology.
Read More
Cross section of brain

Deep brain stimulation of central thalamus restores consciousness in primate models

April 22, 2022
By Bernard Banga
No Comments
A research team led by neuroscientists and neurosurgeons from Paris-Saclay University have recently managed to demonstrate that electrical stimulation of the thalamus can restore consciousness when this has been impaired.
Read More
Carmat featured image

Carmat raises nearly $44M to resume production and implantation of its artificial heart

April 20, 2022
By Bernard Banga
No Comments
Carmat SA just completed a funding exercise, raising nearly $44 million to resume production and implantation of its Aeson total artificial heart, designed for patients suffering from end-stage bi-ventricular heart failure. The capital raise was achieved by issuing 4.05 million new shares on the Paris Euronext exchange, at a fixed price of $10.81 a share.
Read More
Cairdac's device

Cairdac raises $18.5M in funding to develop self-powering leadless pacemaker

April 18, 2022
By Bernard Banga
No Comments
Cairdac SAS closed its first funding round, raising nearly $18.5 million to increase development of an autonomous, leadless pacemaker transcatheter system (ALPS) powered entirely using kinetic energy from the heart. Five French private equity funds and banks participated in this series A round.
Read More
Map of Europe, Medical Device Regulation (MDR) text

France and Germany warn of collapse in patient care unless MDR transition period extended

April 13, 2022
By Bernard Banga
No Comments
The German Medical Technology Association, BVMed, and the French medical technology industries association, SNITEM, have issued a joint warning highlighting the risk of collapse in patient care throughout the EU.
Read More
Close-up of eye with digital focus

Meduni Vienna develops eye scanner for detecting early-stage neurodegenerative conditions

April 11, 2022
By Bernard Banga
No Comments
Meduni Vienna, the Medical University of Vienna, Austria, is working on a novel eye scanner combining the structural and functional sensitivity of optical coherence tomography (OCT) with the chemical specificity of Raman spectroscopy, to acquire data from the living human eye.
Read More
Computer screen displaying Keops software

SMAIO raises $10M in IPO to ramp commercial roll-out of its spinal fusion technology

April 7, 2022
By Bernard Banga
No Comments
Software Machines and Adaptive Implants in Orthopedics (SMAIO) SA raised $10 million on the Paris Euronext Growth market. The offer price was set at $6.66 a share. “Thanks to this IPO, we will now be able to ramp commercial development of our I-Kontrol arthrodesis platform in Europe and secure a foothold in the United States,” Philippe Roussouly, CEO of SMAIO SA, told BioWorld.
Read More
View All Articles by Bernard Banga

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 13.
  • Hearing ear icon

    Cochlear to acquire rival Oticon Medical for $121M

    BioWorld MedTech
    Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it...
  • Illustration of cancer cells and immunotherapy treatment

    Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics

    BioWorld
    After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing